UPDATES ON MANAGEMENT OF IRRITABLE BOWEL SYNDROME
UPDATES ON MANAGEMENT OF IRRITABLE BOWEL SYNDROME UPDATES ON MANAGEMENT OF IRRITABLE BOWEL SYNDROME
Alosetron• Ischemic colitis (0.1‐1% ) , severe constipation (28% )• Withdrawn from market in Nov 2000• Reintroduce in June 2002 with strict prescribingregulations• Indications :• NNT : 7women with severe diarrhea‐predominant symptoms >6 monthsFail conventional treatment• GOR : 1B
Summary of Treatment forIBS‐associated DiarrheaGOR Benefits S/ELoperamide 2C Diarrhea ConstipationParalytic ileusAlosetron 1B DiarrheaGlobalSevere constipationischemic colitis
- Page 9 and 10: Clinical manifestations• Othersbe
- Page 13 and 14: DIAGNOSIS
- Page 15 and 16: Manning criteria• > 3 of the foll
- Page 17 and 18: Symptom‐based diagnosticcriteriaL
- Page 19 and 20: How alarming ?SensitivitySpecificit
- Page 21 and 22: Diagnosis• Consensus statement is
- Page 23 and 24: Emerging specific Investigations•
- Page 25 and 26: PATHOPHYSIOLOGY
- Page 27 and 28: Genetic predisposition• Similar s
- Page 29 and 30: Visceral Hypersensitivity andBrain
- Page 31 and 32: Small Intestine BacterialOvergrowth
- Page 33 and 34: Psychological Dysfunction• Not et
- Page 35 and 36: General PrincipleNon pharmacologica
- Page 37: Compare components of placebo effec
- Page 40 and 41: Outcomes at six week follow-upKaptc
- Page 42 and 43: Patient Education• Explain about
- Page 44: Psychosocial Therapies• Interpers
- Page 48 and 49: Pharmacological treatment• IBS wi
- Page 51 and 52: NNT=5(95% CI 4‐9 )
- Page 53 and 54: Anti‐depressantsSSRI• Less publ
- Page 55 and 56: Psychosocial TherapiesCBT• Cognit
- Page 57 and 58: IBS WITH DIARRHEA
- Page 59: Alosetron• 1 st IBS specific medi
- Page 63 and 64: FiberNNT: 11(95%CI ,5‐100)
- Page 65: Tegaserod• Only 5HT4 Receptor ago
- Page 69 and 70: Lubiprostone• Selective C‐2 chl
- Page 71 and 72: Summary of Treatment forIBS‐assoc
- Page 73 and 74: Alternative Therapies• Peppermint
- Page 77 and 78: CASE SCENARIOIS IT REALLY IBS?
- Page 79 and 80: Ms.Cheung• Is it IBS?• Given ch
- Page 81 and 82: Mr.Leung• Is it IBS?• CT abdome
- Page 83 and 84: Points to note• Red flags for a c
Alosetron• Ischemic colitis (0.1‐1% ) , severe constipation (28% )• Withdrawn from market in Nov 2000• Reintroduce in June 2002 with strict prescribingregulations• Indications :• NNT : 7women with severe diarrhea‐predominant symptoms >6 monthsFail conventional treatment• GOR : 1B
Change language